Paul Hughes joined Ariel Helwani to discuss his recovery from injury and to criticise what he describes as inadequate drug testing in the PFL. Hughes said he underwent knee surgery and also had hip surgery around nine weeks prior, after dealing with hip problems for years. He told Helwani he is focused on rehab and is targeting a return in the first quarter of next year.
The central discussion focused on anti-doping. Hughes alleged that, across his PFL bouts, the only testing he experienced was a urine test the day before fights, with no out-of-competition testing, no whereabouts requirements and no testers visiting his gym. He argued that a predictable, in-competition-only approach is easy to evade and creates a fighter welfare risk.
Hughes said that on the day of the interview he received an email indicating he would be subject to out-of-competition testing for the first time. He questioned the process, saying it appeared to provide advance notice and could include an online, video-supervised test with samples sent back, which he suggested would be open to abuse. He also said he had not been contacted by PFL leadership after speaking publicly on the issue, despite reaching out to people internally.
Elsewhere, Hughes offered his view that Usman Nurmagomedov is likely UFC-bound and gave his assessment of recent UFC match-ups, before briefly turning to a prospective fight with Alfie Davis on his return.
PFL lightweight Paul Hughes says that, in his experience, drug testing in the promotion has amounted to urine testing the day before bouts, with no out-of-competition testing or whereabouts system. Hughes argues this makes it easier for athletes who want to cheat to avoid detection, and frames it as a fighter safety issue.
Read this moment →